Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.
## Primary Indications
* Anxiety disorders
* Insomnia
* Status epilepticus (acute seizure management)
* Preoperative sedation
* Management of alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally two to three times daily. Maximum dose typically 10 mg/day, but depends on severity and individual response.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously (IV) or intramuscularly (IM). A repeat dose of 4 mg may be given 5-10 minutes later if seizures persist, not to exceed a total of 8 mg in the first hour.
* **Preoperative Sedation:** 2 mg to 4 mg IM given 2 hours before surgery.
* **Alcohol Withdrawal:** 2 mg to 4 mg orally or IV/IM every 5-10 minutes as needed for agitation or severe symptoms. Dosing is highly individualized and should be guided by clinical assessment and symptom severity. Some protocols may use higher initial doses.
## Pediatric Dosing
* **Anxiety/Sedation:** Dosing is highly variable and not well-established for routine outpatient use. Doses of 0.02 mg/kg to 0.1 mg/kg orally or IM have been used, not to exceed adult doses.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. A repeat dose of 0.05 mg/kg may be given in 5-10 minutes if seizures persist, not to exceed 0.2 mg/kg total or 8 mg in 24 hours. Dosing requires careful titration and monitoring.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment, but use with caution.
* **Elderly:** Initiate at lower doses (e.g., half of the adult starting dose) and titrate slowly due to increased sensitivity and risk of side effects.
## Contraindications
* Known hypersensitivity to benzodiazepines or their components.
* Acute angle-closure glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, ataxia.
Less Common: Confusion, depression, amnesia, paradoxical excitation, extrapyramidal symptoms, hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants).
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives, antihistamines):** Additive sedative effects, increased risk of respiratory depression and profound sedation.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not significantly by CYP450 enzymes, so interactions are less common than with other benzodiazepines. However, co-administration with potent CYP3A4 inhibitors might theoretically increase lorazepam levels.
* **Theophylline/Aminophylline:** May antagonize the sedative effects of lorazepam.
## Monitoring
* Sedation level and respiratory status, especially after IV/IM administration or in combination with other CNS depressants.
* Cognitive function and risk of falls in the elderly.
* Signs of dependence or withdrawal if used long-term.
* For seizure management, monitor seizure activity and vital signs.
## Clinical Pearls
* Lorazepam has a relatively rapid onset of action, especially with IV/IM administration.
* It is often the benzodiazepine of choice for status epilepticus due to its intermediate half-life and favorable safety profile for acute management.
* Due to its potency and short duration of action, it is less likely to cause significant daytime sedation compared to longer-acting benzodiazepines, but can still occur.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms, including rebound anxiety, insomnia, seizures, and tremors. Tapering is recommended.
* Intravenous lorazepam can cause local irritation; dilute if necessary and administer slowly to minimize adverse reactions.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols for definitive guidance. Dosing may vary based on individual patient factors, clinical context, and local guidelines.*
